JAMES J LOUGHLIN Insider Trading $EDGE PDS Biotechnology Corp

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for JAMES J LOUGHLIN.

Your email is safe with us.
The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of JAMES J LOUGHLIN. JAMES J LOUGHLIN is Director in Tamir Biotechnology, Inc. ($ACEL.OB) and in CELGENE CORP /DE/ ($CELG) and Director in CELGENE CORP /DE/ ($CELG) and Director in Edge Therapeutics, Inc. ($EDGE) and Director in InspireMD, Inc. ($NSPR).

JAMES J LOUGHLIN in PDS Biotechnology Corp

Trading Symbol: EDGE
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of JAMES J LOUGHLIN: Director
Holdings: 26,625 shares
Current Value: $254,269
Latest Transaction: Jul 01 2019
$EDGE Market Capitalization: $272.98M
$EDGE Previous Close: $9.55

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of JAMES J LOUGHLIN in PDS Biotechnology Corp

	1 Week	2 Weeks	1 Month	3 Months	6 Months	1 Year	2 Years
No. of Purchases	0	0	0	0	0	0	0
Value of Purchases ($)	0	0	0	0	0	0	0
No. of Sales	0	0	0	0	0	0	0
Value of Sales ($)	0	0	0	0	0	0	0

Sentiment: All, CELG, NSPR, EDGE, ACEL.OB

Page: 1

Date	Ticker	Company	Owner	Relationship	Transaction	Code	Cost ($)	Shares	Transaction Value ($)	Total Shares	% Holdings
Jul 01 2019	EDGE	PDS Biotechnology ...	LOUGHLIN JAMES J	Director	Option Exercise	A	5.99	9,000	53,910	9,000
Jul 01 2019	EDGE	PDS Biotechnology ...	LOUGHLIN JAMES J	Director	Option Exercise	A	5.99	9,000	53,910	9,000
Mar 18 2019	EDGE	Edge Therapeutics, ...	LOUGHLIN JAMES J	Director	Option Exercise	M	0.00	10,000	0	0
Mar 18 2019	EDGE	Edge Therapeutics, ...	LOUGHLIN JAMES J	Director	Buy	M	0.00	10,000	0	26,625	16.6 K to 26.6 K (+60.15 %)
Aug 15 2018	EDGE	Edge Therapeutics, ...	LOUGHLIN JAMES J	Director	Option Exercise	A	0.00	10,000	0	10,000
Jun 20 2018	EDGE	Edge Therapeutics, ...	LOUGHLIN JAMES J	Director	Option Exercise	A	1.10	20,000	22,000	20,000
Jun 21 2017	EDGE	Edge Therapeutics, ...	LOUGHLIN JAMES J	Director	Option Exercise	A	10.15	15,000	152,250	15,000
Mar 07 2017	EDGE	Edge Therapeutics, ...	LOUGHLIN JAMES J	Director	Buy	P	9.24	3,000	27,720	6,000	3 K to 6 K (+100.00 %)
Jun 23 2016	EDGE	Edge Therapeutics, ...	LOUGHLIN JAMES J	Director	Option Exercise	A	9.34	15,000	140,100	15,000
Mar 15 2016	EDGE	Edge Therapeutics, ...	LOUGHLIN JAMES J	Director	Buy	P	7.63	180	1,373	3,000	2.8 K to 3 K (+6.38 %)
Mar 15 2016	EDGE	Edge Therapeutics, ...	LOUGHLIN JAMES J	Director	Buy	P	7.63	500	3,814	2,820	2.3 K to 2.8 K (+21.55 %)
Mar 15 2016	EDGE	Edge Therapeutics, ...	LOUGHLIN JAMES J	Director	Buy	P	7.64	600	4,583	2,320	1.7 K to 2.3 K (+34.88 %)
Mar 15 2016	EDGE	Edge Therapeutics, ...	LOUGHLIN JAMES J	Director	Buy	P	7.64	1,107	8,456	1,720	613 to 1.7 K (+180.59 %)
Mar 15 2016	EDGE	Edge Therapeutics, ...	LOUGHLIN JAMES J	Director	Buy	P	7.64	500	3,820	613	113 to 613 (+442.48 %)
Mar 15 2016	EDGE	Edge Therapeutics, ...	LOUGHLIN JAMES J	Director	Buy	P	7.63	13	99	113	100 to 113 (+13.00 %)
Mar 15 2016	EDGE	Edge Therapeutics, ...	LOUGHLIN JAMES J	Director	Buy	P	7.58	100	758	100	0 to 100
Oct 08 2015	EDGE	Edge Therapeutics, ...	LOUGHLIN JAMES J	Director	Option Exercise	C	0.00	16,774	0	0
Oct 08 2015	EDGE	Edge Therapeutics, ...	LOUGHLIN JAMES J	Director	Buy	J	8.60	364	3,130	19,625	19.3 K to 19.6 K (+1.89 %)
Oct 08 2015	EDGE	Edge Therapeutics, ...	LOUGHLIN JAMES J	Director	Buy	P	11.00	7,000	77,000	19,261	12.3 K to 19.3 K (+57.09 %)
Oct 08 2015	EDGE	Edge Therapeutics, ...	LOUGHLIN JAMES J	Director	Buy	C	0.00	12,261	0	12,261	0 to 12.3 K

Page: 1